companydata.dkcompanydata.dk

Renovaro Biosciences Denmark ApS: Financial statements 2013

CVR: 26027322

Source: annual report 2013, Danish Business Authority

01/01/2013 – 31/12/2013

Renovaro Biosciences Denmark ApS (CVR 26027322) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -5,558,844 and a net result of DKK -10,561,248. Equity in the 2013 report amounted to DKK -9,478,553.

Gross Profit
DKK -5,558,844
Profit/Loss
DKK -10,561,248
Equity
DKK -9,478,553
Total Assets
DKK 2,075,596

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2013

Renovaro Biosciences Denmark ApS appoints new auditorSep 6, 2013

As of September 6, 2013, CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB has been appointed auditor of Renovaro Biosciences Denmark ApS.

Auditor steps down at Renovaro Biosciences Denmark ApSSep 6, 2013

As of September 6, 2013, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of Renovaro Biosciences Denmark ApS.

Renovaro Biosciences Denmark ApS: The 2012 annual report is outJun 20, 2013

Renovaro Biosciences Denmark ApS has published its annual report for 2012.

Renovaro Biosciences Denmark ApS appoints new auditorJun 19, 2013

As of June 19, 2013, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Renovaro Biosciences Denmark ApS.

Auditor steps down at Renovaro Biosciences Denmark ApSJun 19, 2013

As of June 19, 2013, BAAGØE SCHOU STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of Renovaro Biosciences Denmark ApS.

Niels Erik Nielsen joins the board of Renovaro Biosciences Denmark ApSJun 19, 2013

As of June 19, 2013, Niels Erik Nielsen has joined the board of directors of Renovaro Biosciences Denmark ApS.

Jacob Rosenberg joins the board of Renovaro Biosciences Denmark ApSJun 19, 2013

As of June 19, 2013, Jacob Rosenberg has joined the board of directors of Renovaro Biosciences Denmark ApS.

Aldo Michael Noes Petersen joins the board of Renovaro Biosciences Denmark ApSJun 19, 2013

As of June 19, 2013, Aldo Michael Noes Petersen has joined the board of directors of Renovaro Biosciences Denmark ApS.

Knud Carsten Bernhard Lønfeldt leaves the board of Renovaro Biosciences Denmark ApSJun 19, 2013

As of June 19, 2013, Knud Carsten Bernhard Lønfeldt has left the board of directors of Renovaro Biosciences Denmark ApS.

Peter Buhl leaves the board of Renovaro Biosciences Denmark ApSJun 19, 2013

As of June 19, 2013, Peter Buhl has left the board of directors of Renovaro Biosciences Denmark ApS.

About Renovaro Biosciences Denmark ApS

Renovaro Biosciences Denmark ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Enochian BioSciences Denmark ApS and DanDrit Biotech ApS. The management consists of David Hershel Weinstein. The company is owned by Lunai Bioworks Inc.. The company has 1 employee (2017). In 2026, the company reported a gross profit of DKK -4,478 and a net result of DKK -1,178,038 compared with DKK -4,629,959 the year before. Equity in the 2026 report amounted to DKK -91,933,986.

Source: annual report 2026, Danish Business Authority